74 related articles for article (PubMed ID: 7858550)
1. Failure of high-dose alkylating agents in osteosarcoma. Solid Tumors Working Party.
Colombat P; Biron P; Coze C; Rosti G; Siimes MA; Blay JY; Philip T
Bone Marrow Transplant; 1994 Oct; 14(4):665-6. PubMed ID: 7858550
[No Abstract] [Full Text] [Related]
2. Treatment of solid tumors following allogeneic bone marrow transplantation.
Favre-Schmuziger G; Hofer S; Passweg J; Tichelli A; Hoffmann T; Speck B; Herrmann R; Gratwohl A
Bone Marrow Transplant; 2000 Apr; 25(8):895-8. PubMed ID: 10808212
[TBL] [Abstract][Full Text] [Related]
3. [Intensive chemotherapy and autograft of bone marrow in solid tumors in adults].
Maraninchi D; Viens P; Stoppa AM; Blaise D; Delpero JR; Piana L; Blanc AP; Gaspart MH; Resbeut M; Aime Y
Pathol Biol (Paris); 1989 Feb; 37(2):170. PubMed ID: 2652075
[No Abstract] [Full Text] [Related]
4. [The analysis of failures in therapy of osteosarcoma in children treated according to SFOP-94 protocol in the studies of Polish pediatric solid tumors treatment group].
Chybicka A; Jaworski W; Liebhart M; Gołebiowski W; Kazanowska B; Wecławek-Tompol J; Woźniak W; Kowalczyk J; Katski K; Kołecki P; Boruczkowski D; Leda M
Wiad Lek; 1998; 51 Suppl 4():40-4. PubMed ID: 10731942
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
[TBL] [Abstract][Full Text] [Related]
6. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
Diaz MA; Vicent MG; Madero L
Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
[TBL] [Abstract][Full Text] [Related]
7. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.
Shpall EJ; Clarke-Pearson D; Soper JT; Berchuck A; Jones RB; Bast RC; Ross M; Lidor Y; Vanacek K; Tyler T
Gynecol Oncol; 1990 Sep; 38(3):386-91. PubMed ID: 2121627
[No Abstract] [Full Text] [Related]
8. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
Lucidarme N; Valteau-Couanet D; Oberlin O; Couanet D; Kalifa C; Beaujean F; Lapierre V; Hartmann O
Bone Marrow Transplant; 1998 Sep; 22(6):535-40. PubMed ID: 9758339
[TBL] [Abstract][Full Text] [Related]
10. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
11. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
13. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
Hale GA
Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
15. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma.
Miniero R; Brach del Prever A; Vassallo E; Nesi F; Busca A; Fagioli F; Albiani R; Picci P; Bacci G; Madon E
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S37-40. PubMed ID: 9989888
[TBL] [Abstract][Full Text] [Related]
17. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation for high-risk pediatric solid tumors.
Perentesis J; Katsanis E; DeFor T; Neglia J; Ramsay N
Bone Marrow Transplant; 1999 Sep; 24(6):609-15. PubMed ID: 10490725
[TBL] [Abstract][Full Text] [Related]
19. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
Houck W; Abonour R; Vance G; Einhorn LH
J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
[TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
